# Kisunla

NDC: 0002-9401
Generic name: donanemab-azbt
Labeler / Manufacturer: Eli Lilly and Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20240702

FDA application: BLA761248

## Active ingredients

- DONANEMAB: 17.5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0002-9401"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0002-9401
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=190352d4-ef62-4679-b4fa-e846e2766afa